Latest Breaking News On - Data safety monitoring board - Page 10 : comparemela.com

Theralase(R) Release s 4Q2023 Interim Financial Statements

Theralase(R) Release s 4Q2023 Interim Financial Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioMichael jewettKristina hacheyCalmette guArkady mandelCompany photo dynamic compoundsHealth canadaBladder cancer forumDevice divisionCanadian urologic associationRegulation services providerDrug divisionAmerican urology associationVenture exchangeTheralase technologies inc

Theralase Technologies Inc : Theralase Release s 4Q2023 Interim Financial Statements

Theralase Technologies Inc : Theralase Release s 4Q2023 Interim Financial Statements
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan antonioKristina hacheyCalmette guArkady mandelDennis riedlMichael jewettCompany photo dynamic compoundsHealth canadaBladder cancer forumDevice divisionCanadian urologic associationTechnologies incTheralase technologies incAmerican urology associationVenture exchange

Panbela Therapeutics, Inc (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript

Operator: Greetings. Welcome to Panbela Therapeutics Fourth Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United statesJennifer simpsonJosh korsenJonathan aschoffJoe pantginisEflornithine pediatric neuroblastoma programAmerican society of hematologyStock market exchangeMoffitt cancer centerUniversity of texas md anderson cancer centerPanbela therapeutics incNational cancer instituteDiabetes research foundationIndiana university school of medicineOncology groupCollege education

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports partnership discussions Continued success of Compassionate/Expanded.

United statesSan diegoNew jerseyJeromed jabbourMatinas biopharmaJody cainAsia pacificJohns hopkinsWorld health organizationData review committeeVanderbilt university medical centerUniversity of californiaUniversity of michiganMemorial sloan kettering cancer centerCompassionate expanded use access programOncology program

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseySan diegoAsia pacificJohns hopkinsJeromed jabbourJody cainMatinas biopharmaUniversity of californiaGenentech incCorporate developmentUniversity of michiganKey program updatesMatinas biopharma holdings incVanderbilt university medical centerMemorial sloan kettering cancer center